Involvement of prostaglandins produced by cyclooxygenase-1 in murine visceronociception induced by phenylquinone

Prostaglandins and Other Lipid Mediators

Volumn 55, Issue 1, 1998, Pages 43-49

  Kusuhara, Hidenobu ^a   Matsuyuki, Hirofumi ^a   Okumoto, Takeki ^a  

^a Research Laboratories   (Japan)

Author keywords

Cyclooxygenase; Inflammatory pain; Mofezolac; MRNA expression; Nociception; Non steroidal anti inflammatory drug; Writhing

Indexed keywords

CYCLOOXYGENASE 1; MOFEZOLAC; PHENYLQUINONE; PROSTAGLANDIN; PROSTAGLANDIN F1 ALPHA;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM CELL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; TIME; VISCERAL PAIN; WRITHING TEST;

6-KETOPROSTAGLANDIN F1 ALPHA; ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOQUINONES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; ISOENZYMES; ISOXAZOLES; MEMBRANE PROTEINS; MICE; PAIN; PERITONEAL CAVITY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0031664473     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00004-5     Document Type: Article

References (26)

1. Moncada S., Ferreira S.H., Vane J.R. Pain and inflammatory mediators. Vane J.R., Ferreira S.H. Handbook of Experimental Pharmacology. 1978;558-616 Springer-Verlag, Berlin.
2. Ferreira S.H. Inflammatory pain, prostaglandin hyperalgesia and the development of peripheral analgesics. Trends Pharmacol. Sci. 2:1981;183-186.
3. Davies P., Bailey P.J., Goldenberg M.M., Ford-Hutchinson A.W. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 2:1984;335-357.
4. Needleman P., Turk J., Jkschik B.A., Morrison A.R., Lefkowith J.B. Arachidonic acid metabolism. Annu. Rev. Biochem. 55:1986;69-102.
5. Simmons D.L., Xie W., Chipman J.G., Evett G.E. Multiple cyclooxygenases Cloning of a mitogen inducible form . Baily J.M. Prostaglandins, Leukotrienes, Lipoxines, and PAF. 1991;67-78 Plenum Press, New York.
6. O'Neill G.P., Ford-Hutchinson A.W. Expression of messenger RNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330:1993;156-160.
7. Xie W.L., Chipman J.G., Robertson D.L., Erickson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA. 88:1991;2692-2696.
8. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS10, a phorbol ester tumor promotor-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:1991;12866-12872.
9. O'Banion M.K., Winn V.D., Young D.A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cuclooxygenase. Proc. Natl. Acad. Sci. USA. 89:1992;4888-4892.
10. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA. 89:1992;7384-7388.
11. DuBois R.N., Awad J., Morrow J., Roberts L.J., Bishop P.R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest. 93:1994;493-498.
12. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:1994;12013-12017.
13. Masferrer J.L., Zweifel B.S., Manning P.T., Hauser S.D., Leahy K.M., Smith W.G., et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA. 91:1994;3228-3232.
14. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., Gregory S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97:1996;2672-2679.
15. Doherty N.S. Mediators of the pain of inflammation. Ann. Rep. Med. Chem. 22:1987;245-252.
16. Hendershot L.C., Forsaith J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J. Pharmacol. Exp. Ther. 125:1958;237-240.
17. Doherty N.S., Beaver T.H., Chan K.Y., Dinerstein R.J., Diekema K.A. The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice The role of prostaglandin and oxygen species . Br. J. Pharmacol. 101:1990;869-874.
18. Gans K.R., Galbraith W., Roman R.J., Haber S.B., Kerr J.S., Schmidt W.K., et al. Anti-inflammatory and safety profile of Dup 697, a novel orally effective prostaglandin synthesis inhibitor. J. Pharmacol. Exp. Ther. 254:1990;180-187.
19. Fujiyoshi T., Dozen M., Ikeda K., Oh-ishi S. Involvement of prostaglandins in kaolin-induced writhing reaction in mice. J. Pharmacobiodyn. 12:1989;476-482.
20. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
21. Tanaka K., Kawasaki H., Kurata K., Aikawa Y., Tsukamoto Y., Inaba T. T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts. Jpn. J. Pharmacol. (Tokyo). 67:1995;305-314.
22. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos M., Jennette J.C., et al. Prostaglandin synthase 2 gene disruption causes renal pathology in the mouse. Cell. 83:1995;473-482.
23. Murray L.M., Lee R., Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:1990;163-170.
24. Kusuhara H., Komatsu H., Hisadome M., Ikeda Y. (±)-3-[4-(2-Dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4-b] pyridine-1-acetic acid (Y-25510) stimulates production of IL-1β and IL-6 at the level of mRNA expression in cultured human monocytes. Int. J. Immunopharmacol. 18:1996;719-728.
25. Dunnett C.W. A multiple comparisons procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
26. Ono N., Yamamoto N., Sunami A., Yamasaki Y., Miyake H. Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug. Folia. Pharmacol. Japan (Tokyo). 95:1990;63-81.